ctrl K

Watchlist Price Alert

TRACON Pharmaceuticals In... (TCON)

OTC: TCON · Real-Time Price · USD

0.03

-0.00 (-6.83%)

At close: Mar 06, 2025, 3:00 PM

TRACON Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	12.04M	n/a	346K	n/a	n/a	3M	8.76M	3.45M
Cost of Revenue	14K	16K	14K	12K	22K	30.46M	19.36M	15.24M
Gross Profit	12.03M	-16K	332K	-12K	-22K	-27.46M	-10.6M	-11.79M
Operating Income	-6.9M	-27.89M	-28.35M	-16.22M	-22.3M	-34.74M	-18.21M	-25.98M
Interest Income	n/a	994K	318K	545K	386K	n/a	n/a	n/a
Pretax Income	-3.59M	-29.14M	-28.67M	-16.77M	-22.67M	-34.96M	-19.1M	-27.01M
Net Income	-3.59M	-29.31M	-28.73M	-17.33M	-22.66M	-34.96M	-19.1M	-27.01M
Selling & General & Admin	6.67M	14.01M	17.55M	8.03M	7.77M	7.28M	7.61M	7.86M
Research & Development	12.28M	13.89M	11.15M	8.2M	14.53M	30.46M	19.36M	21.57M
Other Expenses	n/a	-1.24M	-320K	-7K	-378K	12K	n/a	n/a
Operating Expenses	18.93M	27.89M	28.69M	16.22M	22.3M	37.74M	26.96M	29.43M
Interest Expense	7.3M	994K	318K	545K	386K	231K	886K	1.12M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	18.94M	27.89M	28.69M	16.22M	22.3M	37.74M	26.96M	29.43M
Income Tax Expense	n/a	177K	59K	551K	-16K	12K	845K	938K
Shares Outstanding (Basic)	1.63M	1.05M	862.63K	448.53K	151.72K	134.73K	84.03K	63.39K
Shares Outstanding (Diluted)	1.64M	1.05M	862.63K	449.21K	151.72K	134.73K	84.03K	63.39K
EPS (Basic)	-2.2	-28.02	-33.3	-38.63	-149.35	-259.47	-227.33	-426.06
EPS (Diluted)	-2.19	-28.02	-33.3	-38.57	-149.35	-259.47	-227.33	-426.06
EBITDA	-6.88M	-27.89M	-28.33M	-16.22M	-22.27M	-34.71M	-18.17M	-25.8M
EBIT	3.72M	-28.14M	-28.35M	-16.23M	-22.29M	-34.73M	-18.22M	-25.89M
Depreciation & Amortization	14K	16K	14K	12K	22K	28K	48K	94K